SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
198 hedge funds and large institutions have $411M invested in Sage Therapeutics in 2025 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 50 increasing their positions, 53 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.44% more ownership
Funds ownership: 83.74% → 84.18% (+0.44%)
6% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 53
20% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $2.63M
Holders
198
Holding in Top 10
2
Calls
$2.1M
Puts
$2.63M
Top Buyers
| 1 | +$35.6M | |
| 2 | +$21.7M | |
| 3 | +$16.2M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$14M |
| 5 |
D.E. Shaw & Co
New York
|
+$10.9M |
Top Sellers
| 1 | -$32.7M | |
| 2 | -$25.4M | |
| 3 | -$24.2M | |
| 4 |
RI
RTW Investments
New York
|
-$16.3M |
| 5 |
Millennium Management
New York
|
-$10.4M |
